ÂÜÀòÂÒÂ×

Dianne van Strijp is currently a Product Application Specialist at InnoSIGN, where they commercialize mRNA-based OncoSIGNal pathway activity profiling technology for precision medicine. Prior to this role, Dianne worked at Philips as a Scientist, focusing on oncology assays and developing the prognostic prostate biomarker PDE4D7. Before Philips, Dianne was a Scientist at bioMérieux, working on real-time NASBA amplification platforms and molecular assays for virus and bacteria detection. Dianne also has experience as a Research Engineer at Utrecht University, specializing in protein synthesis initiation mechanisms. Dianne studied at Fontys University of Applied Sciences.